Posted on: 06-29-2012 Posted in: News
Inside Washington’s FDA Week – Groups Push Plasma Protein Therapy Exclusion from Biosimilars Pathway, June 29, 2012
FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products.
Promoting the IDF 2013 National Conference on Baltimore TV Station, WJZ
Think Zebra: Student’s Awareness Campaign Aids Immune Deficiency Effort
Grifols Officially Inaugurates New Immunoglobulin Plant in the US
Foundation in Towson Helps People Nationwide with Immune Deficiencies